The South African Health News Service
Subscribe
Find a Clinic
Medicine Price Registry
Return to Content

SA’s HIV score: ‘A’ for meds, ‘F’ for condoms

January 31, 2019
News  

While South Africa has increased HIV spending at district level with stellar results, access to condoms has plummeted, according to the latest District Health Barometer (DHB).

Many HIV convictions not supported by science

July 26, 2018
News  

AMSTERDAM – The prosecution of HIV positive people for deliberately infecting or endangering others is often not supported by science, according to 20 top scientists including Nobel Laureate Francoise Barre-Sinoussi.

First doctor to prescribe ARVs forced to leave SA

June 27, 2018
Human Resources  

A seven-year battle with the Health Professions Council of South Africa (HPCSA) has left legendary French HIV expert Dr Francoise Louis with no choice but to leave the country.

Birth defects fears prompt warnings about new ARV

May 28, 2018
News  

Within a week the “revolutionary” new HIV drug dolutegravir has gone from panacea to pariah. Recent data from a Botswana study linking the drug to birth defects has seen the highest international health bodies issuing public warnings.

Limpopo Health cuts ties with ARVs distributor

May 22, 2018
HIV Treatment   News   OurHealth  

LIMPOPO – The South African Human Rights Commission (SAHRC) will be monitoring the readiness of public health facilities in Moutse before the Department of Health begins the process of transferring HIV patients from the Ndlovu Care Group into public health facilities of their choice.

New medicine dispensing model a hit in Mpumalanga

January 25, 2018
News   OurHealth  

The new, recently introduced Central Chronic Medicines Dispensing and Distribution (CCMDD) programme for patients on antiretrovirals and other chronic medication has already proven to be a major benefit.

Miracle HIV cure man visits SA

September 12, 2017
HIV Treatment  

Timothy Ray Brown is one in 70 million – the only person in the world who has been cured of HIV.